Dr. Tracy Frech, a rheumatologist from the University of Utah discusses her work with Corbus Pharmaceuticals to address systemic sclerosis (SSc) through a disease state education program with a new website geared towards physicians. The program will provide resources to better equip them for treating their patients and understanding the need to address the totality of SSc, a rare, complex and debilitating disease.
TracyFrech, M.D., M.S. serves as the Director of the Systemic Sclerosis (SSc, scleroderma) Clinic at the University of Utah Hospital and the Director of Clinical Trials for the Division of Rheumatology. Her research interests include the vascular aspects of autoimmune disease, primarily vascular leak andSSc. She has participated in many single and multi-center trials and has published several articles in peer-review journals.